Accès gratuit
Numéro
Obésité
Volume 11, Numéro 1, Mars 2016
Page(s) 56 - 60
Section Revue de Presse / Press Review
DOI https://doi.org/10.1007/s11690-016-0517-x
Publié en ligne 16 février 2016
  • Mingrone G, Panunzi S, De Gaetano A, et al (2015) Bariatricmetabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 386:964–73 [CrossRef] [PubMed] [Google Scholar]
  • Mingrone G, Panunzi S, De Gaetano A, et al (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366:1577–85 [CrossRef] [PubMed] [Google Scholar]
  • Buse JB, Caprio S, Cefalu WT, et al (2009) How do we define cure of diabetes? Diabetes Care 32:2133–5 [CrossRef] [PubMed] [Google Scholar]
  • Ikramuddin S, Korner J, Lee WJ, et al (2013) Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 309:2240–9 [CrossRef] [PubMed] [Google Scholar]
  • Schauer PR, Bhatt DL, Kirwan JP, et al (2002) Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 370–13 [PubMed] [Google Scholar]
  • Keating C, Neovius M, Sjoholm K, et al (2015) Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status: results from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol 3:855–65 [CrossRef] [Google Scholar]
  • Sjostrom L (2013) Review of the key results from the Swedish Obese Subjects (SOS) trial a prospective controlled intervention study of bariatric surgery. J Intern Med 273:219–34 [CrossRef] [PubMed] [Google Scholar]
  • Aron-Wisnewsky J, Clement K (2015) The gut microbiome, diet, and links to cardiometabolic and chronic disorders. Nat Rev Nephrol doi: 10.1038/nrneph.2015.191 [Google Scholar]
  • Bruinsma BG, Uygun K, Yarmush ML, et al (2015) Surgical models of Roux-en-Y gastric bypass surgery and sleeve gastrectomy in rats and mice. Nat Protoc 10:495–507 [CrossRef] [PubMed] [Google Scholar]
  • Rubino F, Amiel SA (2014) Is the gut the “sweet spot” for the treatment of diabetes? Diabetes 63:2225–8 [CrossRef] [PubMed] [Google Scholar]
  • Zellmer JD, Mathiason MA, Kallies KJ, et al (2014) Is laparoscopic sleeve gastrectomy a lower risk bariatric procedure compared with laparoscopic Roux-en-Y gastric bypass? A meta-analysis. Am J Surg 208:903–10; discussion 909–10 [CrossRef] [PubMed] [Google Scholar]
  • Chang SH, Stoll CRT, Song J, et al (2014) The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg 149:275–87 [CrossRef] [PubMed] [Google Scholar]
  • Lazzati A, Audureau E, Hemery F, et al (2015) Reduction in early mortality outcomes after bariatric surgery in France between 2007 and 2012: a nationwide study of 133,000 obese patients. Surgery doi:10.1016/j.surg.2015.08.005 [Google Scholar]
  • Golomb I, Ben David M, Glass A, et al (2015) Long-term metabolic effects of laparoscopic sleeve gastrectomy. JAMA Surg 150:1051–7 [CrossRef] [PubMed] [Google Scholar]
  • Cho JM, Kim HJ, Menzo EL, et al (2015) Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: systemic review and meta-analysis. Surg Obes Relat Dis doi:10.1016/j.soard.2015.03.001 [Google Scholar]
  • Schauer PR, Bhatt DL, Kirwan JP, et al (2014) Bariatric surgery versus intensive medical therapy for diabetes — 3-year outcomes. N Engl J Med 370:2002–13 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.